The estimated Net Worth of Sharon O'kane is at least $745 Tysiąc dollars as of 15 June 2024. Sharon kane owns over 2,680 units of LivaNova PLC stock worth over $510,277 and over the last 8 years he sold LIVN stock worth over $0. In addition, he makes $234,890 as Independent Director at LivaNova PLC.
Sharon has made over 11 trades of the LivaNova PLC stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 2,680 units of LIVN stock worth $127,166 on 15 June 2024.
The largest trade he's ever made was exercising 3,327 units of LivaNova PLC stock on 5 August 2017 worth over $157,866. On average, Sharon trades about 1,081 units every 162 days since 2016. As of 15 June 2024 he still owns at least 10,754 units of LivaNova PLC stock.
You can see the complete history of Sharon kane stock trades at the bottom of the page.
Dr. Sharon O'Kane, Ph.D., is an Independent Director of the Company. She was also an expert advisor to the Stevenage Bioscience Catalyst Facility at GlaxoSmithKline, a global healthcare company (2012 to 2019) and a Commercial Mentor to Queen’s University, Belfast (2016 to 2019). Previously, Dr. O’Kane served as Entrepreneur in Residence at the University of Manchester Intellectual Property Company UMIP (2009 to 2014). Dr O’Kane co-founded and, from 1998 to 2010, was the Chief Scientific Officer, and a Director of Renovo Group Plc, a UK biotech company. Dr. O’Kane earned a B.Sc (Honours) First Class in Biomedical Sciences from the University of Ulster from which she also earned a Ph.D. in Biomedical Sciences. She also earned a Diploma in Company Direction from the Institute of Directors.
As the Independent Director of LivaNova PLC, the total compensation of Sharon Kane at LivaNova PLC is $234,890. There are 12 executives at LivaNova PLC getting paid more, with Damien McDonald having the highest compensation of $7,131,930.
Sharon Kane is 52, he's been the Independent Director of LivaNova PLC since 2015. There are 16 older and 5 younger executives at LivaNova PLC. The oldest executive at LivaNova PLC is Arthur Rosenthal, 73, who is the Independent Director.
Sharon's mailing address filed with the SEC is 20 EASTBOURNE TERRACE, , LONDON, X0, W2 6LG.
Over the last 9 years, insiders at LivaNova PLC have traded over $79,802,010 worth of LivaNova PLC stock and bought 4,000 units worth $268,530 . The most active insiders traders include William A Kozy, Two S.C.A.Tower 6 S. A R.L.... oraz Peter M Wilver. On average, LivaNova PLC executives and independent directors trade stock every 10 days with the average trade being worth of $315,922. The most recent stock trade was executed by Peter M Wilver on 15 June 2024, trading 2,680 units of LIVN stock currently worth $127,166.
livanova plc is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.at livanova, we understand the importance of bringing both clinical and economic value to our customers. we are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. livanova is listed on the nasdaq stock exchange under the ticker symbol “livn.” livanova has approximately 3,000 employees worldwide. we are headquartered in london (uk) and maintain a presence in more than 100 countries. livanova is a worldwide leader in advanced circulatory support, cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.
LivaNova PLC executives and other stock owners filed with the SEC include: